Immunome, Inc. (IMNM)
22.21
+0.35
(+1.60%)
USD |
NASDAQ |
Mar 02, 16:00
21.95
-0.26
(-1.17%)
Pre-Market: 09:05
Immunome Market Cap : 2.037B for March 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 7.566B |
| Scholar Rock Holding Corp. | 4.435B |
| Stoke Therapeutics, Inc. | 2.096B |
| Nurix Therapeutics, Inc. | 1.626B |
| Prelude Therapeutics, Inc. | 170.36M |
Market Cap Related Metrics
| PS Ratio | 181.90 |
| Price to Book Value | 7.718 |
| Price | 22.21 |
| Earnings Yield | -13.31% |